ID   C1R-sB7
AC   CVCL_6375
DR   CLO; CLO_0002104
DR   ATCC; CRL-2370
DR   NCBI_Iran; C525
DR   Wikidata; Q54807885
RX   PubMed=7960968;
CC   Population: Caucasian.
CC   Characteristics: Secrete HLA-B allele B*07 but does not express surface B*07 (ATCC=CRL-2370).
CC   Transfected with: HGNC; 4932; HLA-B (allele B*07).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2370
ST   Amelogenin: X
ST   CSF1PO: 6,10
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 7,12
ST   D8S1179: 15
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3714 ! HMy2.C1R
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=7960968; DOI=10.1016/0198-8859(94)90074-4;
RA   Hiraki D.D., See-Tho K., Filvaroff E., Krishnaswamy S., de Bello W.,
RA   Taidi-Laskowski B., Grumet F.C.;
RT   "Bioengineered soluble HLA-B7. Genesis, characterization, and
RT   occurrence of dimerization.";
RL   Hum. Immunol. 40:235-246(1994).
//